Cadence, a NYC-based healthtech company enabling health systems to deliver care to patients at home throughout the U.S., raised $100m in Series B funding.
The round was led by Coatue Management, with participation from existing investors General Catalyst and Thrive Capital.
The funding will accelerate the development of the company’s platform to provide data-driven, responsive, and personalized care in the home nationwide.
Led by Chris Altchek, CEO and founder, Cadence is a health technology company helping patient-centric health systems deliver care outside of the hospital. The company’s Sync™ platform combines new technology with clinical excellence, providing its patients a precise and personal level of care through remote patient monitoring and virtual care.
Cadence is built to manage an increasing number of conditions, acuities, and care pathways, and is engineered to get smarter over time.
FinSMEs
14/12/2021